To maintain the objectivity and integrity of the Journal of Public Health and Pharmacy, all individuals involved in the submission, review, and publication process—authors, reviewers, and editorial board members—are required to disclose any potential conflicts of interest. Such conflicts may include financial relationships, personal affiliations, or other factors that could compromise impartial judgment.

• Authors: Must include a statement of disclosure in their manuscripts.
• Reviewers: Are expected to declare any conflicts of interest prior to reviewing a manuscript.
• Editorial Board Members: Must disclose any relevant conflicts during their tenure.

The journal's editorial team will assess all disclosed conflicts and take appropriate actions, including recusal if necessary, to ensure a fair and unbiased evaluation of all submissions.

Human and Animal Rights Policy

Manuscripts reporting studies involving human subjects must adhere to ethical principles outlined in the Declaration of Helsinki. Authors are required to detail the ethical approval obtained from relevant institutional review boards or ethics committees. For studies involving animals, adherence to internationally recognized guidelines, such as those from the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals, is mandatory.

• Human Subjects: Authors must provide details of ethical approval and ensure compliance with ethical standards.
• Animal Research: Authors must state that ethical approval was obtained and that the welfare of animals was considered.

The journal will not consider manuscripts that violate these ethical principles.

Informed Consent Policy

Authors must ensure that informed consent has been obtained from all human subjects participating in their research. Manuscripts should clearly outline the informed consent process, including how consent was obtained and documented.

• Privacy and Autonomy: Authors should respect the privacy and autonomy of individuals participating in their studies.
• Identifying Information: If the manuscript includes identifying information, explicit consent must be obtained from the individuals concerned.
• Vulnerable Populations: Special care must be taken to obtain appropriate consent from vulnerable groups, such as minors or individuals with impaired decision-making capacity.

Failure to comply with these requirements may result in the rejection or retraction of the manuscript. The Journal of Public Health and Pharmacy prioritizes the protection of human research subjects and emphasizes the importance of ethical considerations in research involving human participants.